Concord Medical Services Holdings (CCM) Cost of Revenue (2009 - 2025)

Concord Medical Services Holdings (CCM) has 17 years of Cost of Revenue data on file, last reported at $2.9 million in Q2 2025.

• Quarterly Cost of Revenue fell 14.69% year-over-year to $2.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $13.9 million (up 6.21% YoY) and the FY2025 annual result came in at $62.2 million, down 2.03% from the prior year.
• Cost of Revenue declined to $2.9 million in Q2 2025, from $3.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.9 million in Q2 2022 to a low of $2.1 million in Q2 2021.
• A 5-year average of $3.2 million and a median of $3.4 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2021 — Cost of Revenue tumbled 32.33% — and 2022, when it surged 86.39%.
• Tracing CCM's Cost of Revenue over 5 years: stood at $2.1 million in 2021, then surged by 86.39% to $3.9 million in 2022, then declined by 7.83% to $3.6 million in 2023, then decreased by 5.45% to $3.4 million in 2024, then decreased by 14.69% to $2.9 million in 2025.
• The last three Cost of Revenue figures came in at $2.9 million (Q2 2025), $3.4 million (Q2 2024), and $3.6 million (Q2 2023), per Business Quant data.